Press release
Henry Schein Reports First Quarter 2025 Financial Results
First-quarter 2025 GAAP diluted EPS of $0.88, growth of 22% compared to the first quarter of 2024 First-quarter 2025 non-GAAP diluted EPS of $1.15, growth of
About this update from Henry Schein, Inc.
[{"type":"text","content":"\n\nFirst-quarter 2025 GAAP diluted EPS of $0.88, growth of 22% compared to the first quarter of 2024\n\n\nFirst-quarter 2025 non-GAAP diluted EPS of $1.15, growth of 4.5% compared to the first quarter of 2024\n\n\nMaintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4%\n\n\nRepurchased $161 million of common stock, or approximately 2.3 million shares\n\n\n\n MELVILLE, N.Y.--(BUSINESS WIRE)--\nHenry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 29, 2025.\n\n“We are pleased with our first quarter financial results as well as the momentum we are seeing heading into the second quarter and remain confident in the fundamentals of our business,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.\n\n“We are advancing our BOLD+1 Strategic Plan, which has been refreshed for 2025 to 2027, with our team focused on growing the distribution business through increasing operational efficiency and enhancing customer experience, growing our dental and medical specialty businesses and corporate brand products, and further developing our digital footprint and digital solutions. We remain committed to our long-term financial goal of high-single-digit to low-double-digit earnings growth by continuing to successfully execute against this strategy,” Mr. Bergman added.\n\nFirst Quarter 2025 Financial Results\n\n\nTotal net sales for the quarter were $3.2 billion:\n\n\nConstant currency total net sales increased 1.4% compared with the first quarter of 2024. Excluding the impact of personal protective equipment (PPE) and COVID test kits, constant currency sales growth was 2.0%.\n\n\nAs-reported total net sales decreased 0.1% due to a stronger U.S. dollar versus the first quarter of last year.\n\n\n\n\nGlobal Distribution and Value-Added Services sales for the quarter increased 0.8% in constant currencies compared with the first quarter of 2024, and increased 1.5% excluding the impact of PPE and COVID test kits. As-reported sales decreased 0.7%. The main components include:\n\n\nGlobal Dental Distribution merchandise sales for the quarter increased 0.4% in constant currencies co...